4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Diabetes Mellitus, Type 1 in 2 studies
WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cetkovic-Cvrlje, M | 2 |
| Olson, M | 1 |
| Ghate, K | 1 |
| Dragt, AL | 1 |
| Vassilev, A | 1 |
| Liu, XP | 1 |
| Uckun, FM | 1 |
2 other studies available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Targeting Janus tyrosine kinase 3 (JAK3) with an inhibitor induces secretion of TGF-β by CD4+ T cells.
Topics: Animals; Apoptosis; CD4 Lymphocyte Count; Cells, Cultured; Cytoprotection; Diabetes Mellitus, Type 1 | 2012 |
Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice.
Topics: Adoptive Transfer; Animals; Cytokines; Diabetes Mellitus, Type 1; DNA-Binding Proteins; Dose-Respons | 2003 |